Journal Guide

Journal of Cerebral Blood Flow & Metabolism stands at the interface between basic and clinical neurovascular research, and features timely and relevant research highlighting experimental, theoretical, and clinical aspects of brain circulation, metabolism and imaging. The journal is relevant to any physician or scientist with an interest in brain function, cerebrovascular disease, cerebral vascular regulation and brain metabolism, including neurologists, neurochemists, physiologists, pharmacologists, anesthesiologists, neuroradiologists, neurosurgeons, neuropathologists and neuroscientists.

The Journal of Clinical Apheresis publishes articles dealing with all aspects of hemapheresis. Articles welcomed for review include those reporting basic research and clinical applications of therapeutic plasma exchange, therapeutic cytapheresis, therapeutic absorption, blood component collection and transfusion, donor recruitment and safety, administration of hemapheresis centers, and innovative applications of hemapheresis technology. Experimental studies, clinical trials, case reports, and concise reviews will be welcomed.

Journal of Hematology & Oncology provides a forum for top-quality research in the fields of hematology and oncology.

The Journal of Leukocyte Biology (JLB) has its origins in the Journal of the Reticuloendothelial Society (JRES) and is today an increasingly highly recognized international journal reporting scientific advances in leukocyte biology.In 1922, Karl Albert Ludwig Aschoff (1866–1942) coined the term “reticuloendothelial system” (RES) [1]. The RES concept was introduced as early as 1914 by Kenji Kiyono (1855–1955). One of the most prominent characteristics of RES cells was their propensity for absorption and storage of vital stains in granular form that had been introduced into the blood in solution. .

The Journal of Pediatric Hematology / Oncology reports on major advances in the diagnosis and treatment of cancer and blood diseases in children. Each issue presents informative case studies and original research articles from leading clinicians and investigators worldwide. Also featured are Clinical and Laboratory Observations that provide practical insights into pertinent issues.Website: www.jpho-online.com.Compatibility:

The mission of the Journal of Thrombosis and Haemostasis is to advance science related to the important medical problems of thrombosis, bleeding disorders and vascular biology through the diffusion and exchange of information and ideas within the international research community. The Journal publishes high quality, original research reports, state-of-the art reviews, invited commentary and debate on timely topics, letters and announcements. Editors invite both laboratory and clinical reports. Journal of Thrombosis and Haemostasis is the official journal of the International Society on Thrombosis and Haemostasis. Benefits of joining ISTH include a complimentary subscription to the Society's official journal and reduced congress registration fees. To join ISTH, visit www.isth.org or e-mail to membership@isth.org.

The Journal of Thrombosis and Thrombolysis is a long-awaited resource for contemporary cardiologists, hematologists, vascular medicine specialists and clinician-scientists actively involved in treatment decisions and clinical investigation of thrombotic disorders involving the cardiovascular and cerebrovascular systems. The principal focus of the Journal centers on the pathobiology of thrombosis and vascular disorders and the use of anticoagulants, platelet antagonists, cell-based therapies and interventions in scientific investigation, clinical-translational research and patient care.The Journal will publish original work which emphasizes the interface between fundamental scienctific principles and clinical investigation, stimulating an interdisciplinary and scholarly dialogue in thrombosis and vascualr science. Published works will also define platforms for translational research, drug development, clinical trials and patient-directed applications. The Journal of Thrombosis and Thrombolysis' integrated for

Leukemia covers all aspects of the research and treatment of Leukemia and Allied Diseases. Studies of normal hemopoiesis are covered because of their comparative relevance. Topics of interest include oncogenes, growth factors, stem cells, leukemia genomics, cell cycle, signal transduction, molecular targets for therapy and more.Impact Factor2010 Impact Factor: 8.966*Rank:4/65 Hematology10/184 Oncology*2010 Journal Citation Reports (Thomson Reuters, 2011)Abstracted/indexed inBIOBASE/Current Awareness in Biological SciencesBIOSISCambridge Scientific AbstractsCurrent Advances in Cell and Developmental BiologyCurrent Advances in Genetics and Molecular BiologyCurrent ContentsCurrent Contents/Life SciencesEMBASE/Excerpta MedicaMEDLINE/Index MedicusResearch AlertReference UpdateScience Citation IndexScience Citation Index ExpandedSUBISISSN and eISSNThe international standard serial number (ISSN) for Leukemia is 0887-6924, and the electronic international standard serial number (eISSN) is 1476-5551.

Leukemia & Lymphoma is an international journal that publishes full-length papers and reviews on clinical and therapeutic practice, epidemiological studies and outcomes analysis, laboratory diagnosis, pathology, cytology, ultrastructure, cytogenetics and cellular and molecular immunology of hematologic malignancies; the journal aims at a strong clinical-pathologic correlation. Letters and correspondence to the editors are also accepted on all topics, which are novel and provide new and interesting data for clinicians and postgraduate teaching. In addition, an update is provided on the basic issues and advances in molecular genetics as applied to this field. The journal will provide an important reference source for physicians and scientists who deal essentially with the clinical and laboratory diagnosis, clinical care and therapy of patients with these disorders.

Leukemia Research is an international journal which brings comprehensive and current information to all health care professionals involved in basic and (or) applied clinical research in leukemias, lymphomas, multiple myeloma and other hematologic malignancies. The editors encourage the submission of articles relevant to normal and leukemic hemopoiesis, biochemistry, cell biology, immunology and molecular biology as well as epidemiologic and clinical studies.Specifically, of major interest will be articles that encompass the application of oncogenes, growth factors, cell markers, cell cycle and differentiation agents, novel therapeutics and clinical trials in both the acute and chronic leukemias as well as the myelodysplastic syndromes. In addition we solicit selected articles on the rapidly increasing specialty of marrow or stem cell reconstitution after high dose therapy with curative attempt in patients with a wide range of neoplasms.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Leukemia Research Reports is a new open access, international journal which will deliver timely information online to all health care professionals involved in basic and/or applied clinical research in leukemias, lymphomas, multiple myeloma and other hematologic malignancies. Launched in late 2012, this is an online-only journal, specializing in rapid publication of peer-reviewed clinical research and short form papers, including brief communications, letters to the Editors, images,debate articles and most importantly case reports.The Editors encourage the submission of articles relevant to normal and leukemic hemopoiesis, biochemistry, cell biology, immunology and molecular biology as well as epidemiologic and clinical studies. Leukemia Research Reports' coverage encompasses the application of oncogenes, genomics (gene expression profiles, microRNAs), proteomics growth factors, cell markers, cell cycle and differentiation agents, novel therapeutics and clinical trials in both the acute and chronic leukemias as well as the myelodysplastic syndromes. In addition articles are solicited on the rapidly growing specialty of marrow or stem cell reconstitution after high dose therapy with curative attempt in patients with a wide range of neoplasms.Supported by an author fee of US$600/EUR 458/JPY 46,638 (exclusive of VAT/Sales Tax) the peer-reviewed content will be made available globally.Leukemia Research Reports is the sister journal of Leukemia Research.Abstracting and IndexingLeukemia Research Reports will initially be covered by Scopus and ScienceDirect.

The focus of the journal 'magazine of european medical oncology – memo' is to offer a professional review on current research and development in the field of hematology and oncology relevant for daily practice. Therefore, memo includes editorials and comments, peer-reviewed original reports, short reviews, case reports and controversies, articles explaining the biology of neoplasia and congress reports including qualified comments. As a European journal memo aims at highlighting the local peculiarities of various regions and at being a forum for the presentation of ongoing clinical and basic research.memo is the Official Journal of the Central European Cooperative Oncology Group (CECOG) and The Austrian Society of Haematology and Oncology (OeGHO).

Medical Oncology (MO) communicates the results of clinical and experimental research in oncology and hematology, particularly with experimental therapeutics with the field of immunotherapy and chemotherapy. It also provides state-of-the-art Reviews on clinical and experimental therapies in oncology and hematology. Topics covered include immunobiology, pathogenesis, and treatment of malignant tumors.